NeuroCycle Therapeutics - Ownership and Business Overview

Life ScienceCompany

NeuroCycle Therapeutics Ownership

Who owns NeuroCycle Therapeutics?

NeuroCycle Therapeutics is owned by Engrail Therapeutics. It was acquired on February 2, 2021.

NeuroCycle Therapeutics Business Overview

Where is NeuroCycle Therapeutics headquartered?

NeuroCycle Therapeutics is headquartered in Cambridge, Massachusetts.

What sector is NeuroCycle Therapeutics in?

NeuroCycle Therapeutics is a life science company.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 397 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 351 by strategics.

NeuroCycle Therapeutics, Inc.

1 Broadway,
Cambridge, Massachusetts 02142
United States,
wwww.neurocycletherapeutics.com

NeuroCycle Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small-molecule drugs that target the central nervous system. NeuroCycle Therapeutics is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.